Last edition
News about "generic Jynarque"
Lupin's US Business May Moderate After Strong Q1, Says Equirus Securities
Equirus Securities expects Lupin’s US business to moderate amid rising competition, while new launches and expanding chronic and international portfolios could support overall growth.
Generic Jynarque | 14/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members